Skip to main content
Medical information Clinical review pending

Genetic Testing

Bacterial Genome De Novo Assembly and Annotation Illumina

Identify bacterial infections using advanced genetic analysis. This test sequences and analyzes the entire bacterial genome to help guide treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Confirm with the laboratory before booking. Typically requires a sample containing the bacteria, such as blood, tissue, or other relevant bodily fluid.
Results
Confirm with the laboratory before booking. Results are typically available within 4 weeks.
Preparation
Confirm with the laboratory before booking. Specific preparation instructions may depend on the type of sample required.
Test priceKSh 36,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Bacterial Genome De Novo Assembly and Annotation Illumina test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Persistent or recurrent infections
  • ✓Unexplained symptoms unresponsive to standard treatment
  • ✓Infections in immunocompromised individuals
  • ✓Suspected antibiotic resistance
  • ✓Epidemiological investigation of outbreaks
  • ✓Identification of novel bacterial strains
02

In plain language

What this test helps you understand

Provides comprehensive genetic information about bacterial pathogens, aiding in accurate identification, understanding resistance mechanisms, and guiding targeted antibiotic therapy for complex or persistent infections.
The Bacterial Genome De Novo Assembly and Annotation Illumina test is an advanced genetic diagnostic tool used to identify and analyze bacterial genomes. This test is valuable for understanding complex infections and guiding effective treatment strategies. Using Illumina sequencing technology, it provides detailed insights into the genetic makeup of bacteria, enabling precise identification and characterization.

This test measures and detects the entire genetic sequence of bacterial organisms. It assembles the genome 'de novo' (from scratch, without a reference sequence) and annotates it to provide detailed information about the genes present and their functions. This level of detail is essential for identifying specific bacterial strains and understanding their potential impact on health.

This test is particularly recommended for individuals experiencing persistent or recurrent infections, unexplained symptoms unresponsive to standard treatments, those with compromised immune systems, or patients with a history of antibiotic resistance.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Specific preparation instructions may depend on the type of sample required.
SampleConfirm with the laboratory before booking. Typically requires a sample containing the bacteria, such as blood, tissue, or other relevant bodily fluid.
MethodologyIllumina sequencing technology is used for de novo genome assembly and annotation of bacterial DNA.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies bacteria present in the sample at the time of collection. It may not detect bacteria present in other locations or at different times. Interpretation requires expertise in genomics and microbiology.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

De novo assembly means constructing the genome sequence from scratch, without relying on a pre-existing reference genome. This is useful for identifying novel or highly divergent bacteria.
Annotation involves identifying genes and other functional elements within the assembled genome sequence, providing information about the bacteria's potential functions and characteristics.
This test is generally reserved for complex cases, such as persistent infections, infections in immunocompromised patients, or when antibiotic resistance is suspected, rather than routine infections.
Results require interpretation by a qualified healthcare professional, often in consultation with a microbiologist or geneticist, to understand the clinical significance.
The required sample depends on the suspected site of infection. Common samples include blood, tissue, urine, or swabs. Please confirm specific requirements with the laboratory.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp